Overview
- 4 inspections across 4 sites are on record.
- 7 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-05.
At a glance
Inspections
4
Sites
4
Observations
7
Career since
Sep 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Grifols Therapeutics LLC | 5 Feb 2026 | Biologics | On file |
| ADMA Biologics, Inc | 11 Dec 2024 | Biologics | On file |
| Baxalta US Incorporated | 31 May 2023 | Biologics | On file |
| Octapharma AB | 28 Sep 2018 | Biologics | On file |
Sites inspected
Grifols Therapeutics LLCClayton, United States1 insp.
ADMA Biologics, IncBoca Raton, United States1 insp.
Baxalta US IncorporatedLos Angeles, United States1 insp.
Octapharma ABStockholm, Sweden1 insp.
Co-investigators
Investigators who share inspections with this person.
Eileen A Liu2 shared
Katarzyna I Jankowska1 shared
Brentley S Pittman1 shared
Vijaya L Simhadri1 shared
Thai D Truong1 shared
Burnell M Henry1 shared
Laurel A Beer1 shared
Prabhu P Raju1 shared
Full investigator report
Get the verbatim findings behind Jennifer L Reed's 7 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site